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The reverse transcriptase from AIDS virus, HTLV-III, was purified and characterized. The purified enzyme 
has a very high affinity for template primers (rC);(dG),, and (rCm),$dG),, compared to that for (rA),(dT)r2. 
In addition, the HTLV-III reverse transcriptase was able to transcribe (rAm);(dT),, very efficiently. The 
ionic requirements are unique in the sense that HTLV-III reverse transcriptase prefers Mg2+ as divalent 
ions to transcribe (rC);(dG),, and (rA);(dT),,. The M, of the enzyme is 9~~~.~~ 000. Unlike the WTLV-I 
reverse transcriptase, the HTLV-III enzyme is highly stabh and has a much higher activity in the presence 
of (rt);(dG),,; the P’&,, for HTLV-III reverse transcriptase is several-fold higher than that for HTLV-I en- 
zyme. The enzyme activity of the purified reverse transcriptase from HTLV-III was resolved into two peaks 
on a preparative isoelectric column, one at pH 5.75 and the other at pH 6.25. This leads us to conclude 
that the reverse transcriptase of HTLV-III is biochemically heterogeneous. 
Reverx tra~~criptase heterogeneity 
Human T-cell leukemi~/lymphoma virus 
(HTLV) was the first human retrovirus identified 
as an infectious agent etiologically associated with 
adult T-cell leukemia [I]. A related but distinct 
retrovirus was isolated from a T-cell variant of 
hairy cell leukemia [Z]. Both the viruses show a 
tropism for T cells, particularly OKT4+ cells, and 
have the capacity of immortalizing and transform- 
ing normal human T cells in culture [3,4], These 
viruses have been subclassified as HTLV-I and 
HTLV-II, respectively. Because of their T-cell 
tropism, particularly for OKT4’ cells, and other 
biological properties [5,6], the search for a similar 
retrovirus associated with the acquired immune 
deficiency syndrome (AIDS) was implicated, Gallo 
and his associates [7] succeeded in isolating and 
characterizing a retrovirus associated with AIDS, 
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which was shown to be biologically and morpho- 
fogicahy distinct from HTLV-I and HTLV-II. 
However, due to some homologic gene suequences 
between the AIDS-associated virus and HTLV-I 
and HTLV-II [8], this virus has been termed 
HTLV-III. Other investigators have also reported 
virus isolates with properties similar to those of 
HTLV-III, from patients with lymphadenopathy 
syndrome and AIDS 191. 
Compared to the other T-lymphotropic retro- 
viruses, HTLV-I and HTLV-II, the AIDS-asso- 
ciated viruses are non-transforming cytopathic 
viruses without immortalizing activity. Thus, virus 
replication is an important event in the progress of 
this disease, and the interruption of viral replica- 
tion offers an important strategy for the control of 
AIDS, The development of reverse transcriptase 
inhibitors is, therefore, a useful approach in 
designing potential therapeutic agents against 
AIDS. For this reason, we have purified reverse 
transcriptase from the AIDS-associated virus 
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HTLV-III and characterized it biochemic~ly. The 
purified reverse transcriptase from HTLV-III 
shows some novel features which we have not 
observed thus far in reverse transcriptases purified 
from human tumor cells and tissues [lo]. Here we 
describe some of the distinguishing features of 
HTLV-III reverse transcriptase which may be 
useful for analyzing the virus-associated enzyme 
activity in biological specimens from AIDS pa- 
tients, and in designing its specific inhibitors. 
2. EXPERIMENTAL 
The enzyme from HTLV-III-infected H9 cells, 
or HTLV-III suspensions (obtained from Dr R.C. 
Gallo and Dr P.S. Sarin, National Cancer in- 
stitute, Bethesda, MD) was purified by successive 
chromatography on DE~~ellulose (DE23 and 
DE52) and phosphocellulose columns. A single 
peak of high reverse transcriptase activity was 
eluted from the phosphocellulose column at a salt 
concentration of 0.175 M KCl. This peak of activi- 
ty was unable to transcribe the template primers 
(dC), . (dG)iz and (dA)* * (dT)it, indicating that 
no DNA-dependent DNA polymerase activities 
were present in this fraction. A quantitative 
analysis of the enzyme at various purification steps 
showed a 120-140-fold purification, starting from 
the crude fraction obtained after ~entrifugation at 
170 000 x g ill]. 
DNA polymerase activity was measured by ad- 
ding 20 81 of the enzyme fraction to a volume of 
30~1, which gave a final concentration of 50 mM 
Tris-HCl buffer (pH 8.0), 50 mM KCl, divalent 
ions (as indicated in table l), 1 mM dithiothreitol, 
20 FM each of complementary dNTP, or ‘H- 
labeled substrate and 1.25 fig template primer (as 
listed in table 1). The reaction mixtures were in- 
cubated for 30 min at 37°C. The reaction was stop- 
ped by the addition of 0.36 mg bovine serum 
albumin and 3 ml trichloroacetic acid (lo%, w/v) 
containing 20 mM sodium pyrophosphate. Acid- 
precipitable material was collected on Whatmn 
GF/C glass fibre discs, washed and counted in a 
scintillation spectrometer. Each assay was carried 
out in triplicate. 
The M, of the purified reverse transcriptase was 
determined by gel filtration on an Ultrogel AcA 44 
(LKB, Munich) column. The gel, as supplied by 
LKB, was poured into a column (1 x 40 cm) and 
equiIibrated with buffer (pH 7.5) containing 50 
mM Tris-HCl. Protein markers (collagenase, M, 
10900), bovine serum albumin (i%& 67 000) and 
chicken albumin (MI 45000) were purified before 
use. The enzyme activity eluted from the column 
was assayed in the presence of (rC), 1 (dG)rz using 
Mg’+ (15 mM) in the standard reaction mixture 
described above. 
Preparative electrofocusing in a pH gradient was 
carried out at 4’C on 110 ml columns (LKB 
8100-l). The sample (400-500 pg protein) was 
distributed throughout the column by mixing car- 
rier ampholytes (Ampholines, LKB) of pH ranges 
3-10 (1 part) and 5-8 (2 parts) in a IO-60% (w/v) 
glycerol gradient. Electrofocusing was performed 
at 1600 V. Fractions were collected and assayed in 
the presence of (rC),*(dG)iz using Mg2+ (15 mM) 
in the standard reaction mixture, as indicated in 
table 1, 
3. RESULTS AND DISCUSSION 
The purified and concentrated enzyme was 
tested with various template primers in the 
presence of different concentrations of divalent 
cations. These assays are useful in deriving infor- 
mation as to whether cellular DNA polymerases 
are present, and whether the enzyme has a type 
specificity; for example, mammalian viruses of the 
C-type have different ionic requirements from 
viruses belonging to the B-type. As follows from 
table 1, the purified enzyme transcribes 
(rA)n*(dT)12, (rAm),* (dT)l2, (rC),-(dGh and 
(rCm),*(dG)r2; primer alone with either cation 
gives no activity. The pattern of template primer 
utilization by the enzyme distinguishes it from ter- 
minal deoxynucleotidyltransferase and host DNA 
polymerases. Another property unique to reverse 
transcriptase is its capacity to catalyze transcrip- 
tion of the viral RNA (70 S RNA). This was con- 
firmed for the HTLV-III enzyme using a purified 
70 S RNA from SSAV. 
Except for the transcription of 2’-O-methylated 
templates, (rAm)” and (rCm),, all other template 
primers require Mg2+ for optimal activity. The 
fact that (rC), - (dG)iz-dependent activity is several- 
fold bigher’than that catalyzed by (rA)n*(dT)rz and 
is strictly magnesium-dependent constitutes a 
novel feature of the HTLV-III enzyme, compared 
to known properties of other C-type virus reverse 
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Table 1 
Tempfate primer requirements of the purified reverse transcriptase from HTLV-III 
,,.” I -,I -. .I ““._^ 
Template primer 3H-labeled Enzyme activity per h (pmol/pg protein h) 
substrate 
Mg” (mM) Mn” (mM) 
(rA~~-tdT~I2 
@Am)=. Wh 
(0,. Wh 
(rem), . @% 
70 S RNA (SSAV) 
70 S RNA -t (dTjr2 
(WltrZ 
dTTF 
dTTF 
dGTP 
dOTP 
dGTP 
dGTP 
dGrP 
15.45(0.5) 0.23(0*05) 
0.18(3.0) 94.77jO.05) 
273.9O(ls.O) 0.74(0.075) 
J&X7(3.0) 89.03(0.2) 
1.79(10.0) 0 
4*7~(~0.0~ 0 
O.OlfO.5~ tt 
Assays were performed with the same batch of enzyme using the same concentration. 
Viral RNA (70 S) was tested in the presence of 3 other cold dNTFs with the indicated 
radioactive dNTP. DNA polymerase activity was measured by adding 20 ~1 of the en- 
zyme fraction to a volume of 30~1, which gave a final concentration of 50 mM Tris- 
HCli buffer (pH g..O), 50 mM RCI, divalent cations (as ind~~a~)~ 1mM d~th~othre~to1, 
2OpM each of the complementary dNTF, or AH-Iabel~ substrate and f .25Fg template 
primer (as indicated). Other conditions are described in section 2 
i 
I I I -L.. 
26 32 36 40 44 48 52 56 60 $4 66 72 76 
ELURTE [ml) 
Fig. f . Dete~~~at~o~ f the M, of the HTLV-III enzyme by gef fiftratkrx on Uftrogel AcA 44, The enzyme activity efuted 
from the column was assayed in the presence of (rC),q(dG)~t using Mg’+ (l5 mM) in the standard reaction mixture 
described in section 2. 
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transcriptases. In this respect, the enzyme 
resembles more closely reverse transcriptases from 
B- and D-type viruses. 
The M, of HTLV-II enzyme was determined by 
gel filtration (Ultrogel AcA 44) using purified pro- 
tein markers (Mr 45000-109000). The HTLV-II 
enzyme activity was recovered as a single peak in 
the range M, 95 000-98000 (fig.1). With few ex- 
ceptions [l 1,121, most of the C-type viral reverse 
transcriptases have an M, of about 70000. In this 
respect, the HTLV-III enzyme is another 
exception. 
Our futher attempts to purify the HTLV-III en- 
zyme obtained after phosphocellulose column 
chromatography led to unexpected results. The en- 
zyme purified on phosphocellulose was subjected 
to isoelectric focusing on a preparative column. 
Quite unexpectedly, the HTLV-III reverse tran- 
scriptase activity resolved into two peaks, one at 
pH 5.75 and the other at pH 6.25 (fig.2). This was 
also confirmed by the analytical procedure, where 
the isoelectric focusing was carried out on gels. 
However, we believe that the isoelectric data from 
the preparative procedure, involving a direct 
measurement of the enzyme activity, are more 
reliable and leave no doubt that HTLV-III enzyme 
is heterogeneous with two isoelectric points, 5.75 
and 6.25. In a parallel experiment, we investigated 
the isoelectric behavior of a purified reverse 
transcriptase from HTLV-I and failed to observe 
this type of heterogeneity. At present we cannot 
provide an explanation for the heterogeneity of 
HTLV-III reverse transcriptase. However, two sets 
of experimental observations are relevant to our 
0 . 1 
Fig.2 Profile of DNA 
phosphocellulose column. 
Fraction No. 
polymerase activities after electrofocusing of the HTLV-III enzyme eluted from a 
Experimental details are given in the text. The enzyme activity of the eluted fractions was 
measured in the presence of (rC),. (dG)rz using Mg2+ (15 mM). 
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results: firstty, a similar type of heterogeneity in 
the antigenic proteins of HTLV-III, especially 
P24, has been observed (Sarangadharan, personal 
communication): secondly, HTLV-III differs from 
HTLV-I in the amino-terminal region of the 
second open reading frame as the corresponding 
region of HTLV-I cannot encode a functions pro- 
tease 1131. The second open reading frame 
(nucleotides 1629-4673) encodes the pol gene, the 
reverse transcriptase and a protease at its 5’-ter- 
minus, plus aa endonuclease at its 3’-terminus [131. 
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